Compared with controls, plasma levels of TNF-α (40.36 ± 43.85 pg/ml) and IL-6 (7.43 ± 6.58 pg/ml) were significantly increased in PBC patients (pretreatment) (P < 0.05). The gene discussed is IL6; the disease is primary biliary cholangitis.